A detailed history of High Tower Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 6,022 shares of RGEN stock, worth $823,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,022
Previous 24,072 74.98%
Holding current value
$823,267
Previous $4.43 Million 82.86%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$120.0 - $182.95 $2.17 Million - $3.3 Million
-18,050 Reduced 74.98%
6,022 $759,000
Q1 2024

May 06, 2024

SELL
$170.78 - $208.42 $205,789 - $251,146
-1,205 Reduced 4.77%
24,072 $4.43 Million
Q4 2023

Feb 12, 2024

BUY
$114.17 - $185.35 $48,522 - $78,773
425 Added 1.71%
25,277 $4.54 Million
Q3 2023

Nov 08, 2023

BUY
$138.78 - $176.51 $19,429 - $24,711
140 Added 0.57%
24,852 $3.95 Million
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $992,056 - $1.29 Million
7,167 Added 40.85%
24,712 $3.5 Million
Q1 2023

May 11, 2023

SELL
$154.26 - $198.1 $117,546 - $150,952
-762 Reduced 4.16%
17,545 $2.95 Million
Q4 2022

Feb 08, 2023

BUY
$162.42 - $220.56 $96,639 - $131,233
595 Added 3.36%
18,307 $3.1 Million
Q3 2022

Nov 09, 2022

BUY
$160.42 - $256.21 $33,688 - $53,804
210 Added 1.2%
17,712 $3.32 Million
Q2 2022

Aug 10, 2022

SELL
$140.68 - $188.02 $21,102 - $28,203
-150 Reduced 0.85%
17,502 $2.84 Million
Q1 2022

May 12, 2022

BUY
$161.19 - $257.96 $31,754 - $50,818
197 Added 1.13%
17,652 $3.33 Million
Q4 2021

Feb 10, 2022

SELL
$247.59 - $304.47 $92,846 - $114,176
-375 Reduced 2.1%
17,455 $4.63 Million
Q3 2021

Nov 12, 2021

BUY
$194.77 - $324.21 $217,363 - $361,818
1,116 Added 6.68%
17,830 $5.15 Million
Q2 2021

Aug 06, 2021

SELL
$165.87 - $220.95 $9,786 - $13,036
-59 Reduced 0.35%
16,714 $3.34 Million
Q1 2021

May 10, 2021

SELL
$180.37 - $226.26 $119,765 - $150,236
-664 Reduced 3.81%
16,773 $3.26 Million
Q4 2020

Feb 10, 2021

BUY
$148.08 - $206.57 $45,608 - $63,623
308 Added 1.8%
17,437 $3.34 Million
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $245 - $316
2 Added 0.01%
17,129 $2.53 Million
Q2 2020

Aug 10, 2020

SELL
$94.33 - $140.48 $8,489 - $12,643
-90 Reduced 0.52%
17,127 $2.12 Million
Q1 2020

May 21, 2020

SELL
$84.96 - $109.14 $133,812 - $171,895
-1,575 Reduced 8.38%
17,217 $1.66 Million
Q4 2019

Feb 14, 2020

BUY
$73.84 - $93.08 $125,749 - $158,515
1,703 Added 9.97%
18,792 $1.73 Million
Q3 2019

Nov 12, 2019

SELL
$76.65 - $95.51 $84,315 - $105,061
-1,100 Reduced 6.05%
17,089 $1.31 Million
Q2 2019

Aug 13, 2019

SELL
$54.2 - $85.95 $2,384 - $3,781
-44 Reduced 0.24%
18,189 $1.56 Million
Q1 2019

May 15, 2019

SELL
$49.45 - $62.8 $1,137 - $1,444
-23 Reduced 0.13%
18,233 $1.08 Million
Q4 2018

Feb 14, 2019

SELL
$48.26 - $68.88 $21,620 - $30,858
-448 Reduced 2.4%
18,256 $962,000
Q3 2018

Nov 09, 2018

BUY
$46.8 - $58.97 $3,603 - $4,540
77 Added 0.41%
18,704 $1.04 Million
Q1 2018

May 15, 2018

BUY
$30.92 - $37.27 $9,276 - $11,181
300 Added 1.64%
18,627 $675,000
Q4 2017

Feb 14, 2018

BUY
$32.53 - $38.92 $14,410 - $17,241
443 Added 2.48%
18,327 $665,000
Q3 2017

Nov 14, 2017

BUY
$36.98 - $46.06 $661,350 - $823,737
17,884
17,884 $686,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.